Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, ...

FDA Recall #D-0034-2021 — Class III — September 24, 2020

Recall #D-0034-2021 Date: September 24, 2020 Classification: Class III Status: Terminated

Product Description

Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured by Hi-Tech Pharmacal Co Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01

Reason for Recall

Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.

Recalling Firm

Leadiant Biosciences, Inc. — Gaithersburg, MD

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

1380 bottles

Distribution

PA and Italy

Code Information

Lot #: 370655, Exp. 10/31/2020

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated